4.05 USD
-0.19 (-4.48%)
ChartMill assigns a Buy % Consensus number of 80% to RLMD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.2. This target is 151.85% above the current price.
RLMD was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about RLMD.
In the last month the buy percentage rose by 34 points. So the trust of analysts is improving.
RLMD was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-19 | Mizuho | Upgrade | Neutral -> Outperform |
| 2024-12-05 | Mizuho | Downgrade | Outperform -> Neutral |
| 2024-12-04 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-09-17 | Jefferies | Upgrade | Hold -> Buy |
| 2024-06-05 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2023-06-15 | Mizuho | Reiterate | Buy -> Buy |
| 2023-01-23 | SVB Leerink | Maintains | Outperform |
| 2022-10-14 | Guggenheim | Downgrade | Buy -> Neutral |
| 2022-10-14 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2022-10-13 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2022-09-23 | Goldman Sachs | Maintains | Buy |
| 2022-09-06 | Guggenheim | Maintains | Buy |
| 2022-05-09 | Oppenheimer | Maintains | Outperform |
| 2021-12-20 | SVB Leerink | Maintains | Outperform |
| 2021-11-18 | Mizuho | Initiate | Buy |
RELMADA THERAPEUTICS INC / RLMD FAQ
What is the price target for RLMD stock?
8 analysts have analysed RLMD and the average price target is 10.2 USD. This implies a price increase of 151.85% is expected in the next year compared to the current price of 4.05.
What is the consensus rating for RELMADA THERAPEUTICS INC (RLMD) stock?
The consensus rating for RELMADA THERAPEUTICS INC (RLMD) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.